INTELLINETICS INC (INLX) Fundamental Analysis & Valuation

NYSEARCA:INLX • US45825X2045

Current stock price

7 USD
-0.2 (-2.78%)
Last:

This INLX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. INLX Profitability Analysis

1.1 Basic Checks

  • In the past year INLX has reported negative net income.
  • In the past year INLX had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: INLX reported negative net income in multiple years.
  • Each year in the past 5 years INLX had a positive operating cash flow.
INLX Yearly Net Income VS EBIT VS OCF VS FCFINLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M

1.2 Ratios

  • INLX's Return On Assets of -10.82% is on the low side compared to the rest of the industry. INLX is outperformed by 65.44% of its industry peers.
  • INLX has a Return On Equity (-16.45%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -10.82%
ROE -16.45%
ROIC N/A
ROA(3y)-3.68%
ROA(5y)0.09%
ROE(3y)-5.42%
ROE(5y)7.01%
ROIC(3y)N/A
ROIC(5y)N/A
INLX Yearly ROA, ROE, ROICINLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

1.3 Margins

  • INLX has a Gross Margin (66.59%) which is in line with its industry peers.
  • INLX's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for INLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.29%
GM growth 5Y1.78%
INLX Yearly Profit, Operating, Gross MarginsINLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. INLX Health Analysis

2.1 Basic Checks

  • INLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, INLX has more shares outstanding
  • The number of shares outstanding for INLX has been increased compared to 5 years ago.
  • The debt/assets ratio for INLX has been reduced compared to a year ago.
INLX Yearly Shares OutstandingINLX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
INLX Yearly Total Debt VS Total AssetsINLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • INLX has an Altman-Z score of 1.90. This is not the best score and indicates that INLX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • INLX has a Altman-Z score (1.90) which is in line with its industry peers.
  • The Debt to FCF ratio of INLX is 1.67, which is an excellent value as it means it would take INLX, only 1.67 years of fcf income to pay off all of its debts.
  • INLX has a Debt to FCF ratio of 1.67. This is in the better half of the industry: INLX outperforms 68.38% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that INLX is not too dependend on debt financing.
  • INLX has a Debt to Equity ratio of 0.01. This is in the better half of the industry: INLX outperforms 62.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 1.67
Altman-Z 1.9
ROIC/WACCN/A
WACC10.86%
INLX Yearly LT Debt VS Equity VS FCFINLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that INLX should not have too much problems paying its short term obligations.
  • INLX has a worse Current ratio (1.03) than 74.26% of its industry peers.
  • A Quick Ratio of 1.00 indicates that INLX may have some problems paying its short term obligations.
  • INLX has a Quick ratio of 1.00. This is in the lower half of the industry: INLX underperforms 74.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1
INLX Yearly Current Assets VS Current LiabilitesINLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. INLX Growth Analysis

3.1 Past

  • The earnings per share for INLX have decreased strongly by -266.67% in the last year.
  • INLX shows a decrease in Revenue. In the last year, the revenue decreased by -7.96%.
  • The Revenue has been growing by 14.98% on average over the past years. This is quite good.
EPS 1Y (TTM)-266.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)-7.96%
Revenue growth 3Y5.76%
Revenue growth 5Y14.98%
Sales Q2Q%1.03%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y32.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.82%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
INLX Yearly Revenue VS EstimatesINLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
INLX Yearly EPS VS EstimatesINLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

1

4. INLX Valuation Analysis

4.1 Price/Earnings Ratio

  • INLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INLX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INLX Price Earnings VS Forward Price EarningsINLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

  • The rest of the industry has a similar Price/Free Cash Flow ratio as INLX.
Industry RankSector Rank
P/FCF 284.71
EV/EBITDA N/A
INLX Per share dataINLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INLX Dividend Analysis

5.1 Amount

  • No dividends for INLX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INLX Fundamentals: All Metrics, Ratios and Statistics

INTELLINETICS INC

NYSEARCA:INLX (4/23/2026, 8:18:56 PM)

7

-0.2 (-2.78%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-30
Earnings (Next)05-18
Inst Owners10.69%
Inst Owner Change0%
Ins Owners26.02%
Ins Owner Change0.53%
Market Cap31.29M
Revenue(TTM)16.58M
Net Income(TTM)-1.87M
Analysts82.86
Price Target14.79 (111.29%)
Short Float %0.03%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.02%
Min EPS beat(2)21.57%
Max EPS beat(2)26.47%
EPS beat(4)3
Avg EPS beat(4)-4.2%
Min EPS beat(4)-85.19%
Max EPS beat(4)26.47%
EPS beat(8)4
Avg EPS beat(8)-145.05%
EPS beat(12)6
Avg EPS beat(12)-99.81%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.4%
Min Revenue beat(2)-9.08%
Max Revenue beat(2)2.27%
Revenue beat(4)1
Avg Revenue beat(4)-5.21%
Min Revenue beat(4)-9.08%
Max Revenue beat(4)2.27%
Revenue beat(8)2
Avg Revenue beat(8)-2.73%
Revenue beat(12)4
Avg Revenue beat(12)-1.76%
Revenue beat(16)8
Avg Revenue beat(16)-0.58%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.89
P/FCF 284.71
P/OCF 33.5
P/B 2.75
P/tB 15.84
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)0.02
FCFY0.35%
OCF(TTM)0.21
OCFY2.98%
SpS3.71
BVpS2.55
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -10.82%
ROE -16.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.59%
FCFM 0.66%
ROA(3y)-3.68%
ROA(5y)0.09%
ROE(3y)-5.42%
ROE(5y)7.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.29%
GM growth 5Y1.78%
F-Score5
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 1.67
Debt/EBITDA N/A
Cap/Depr 62.5%
Cap/Sales 4.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1
Altman-Z 1.9
F-Score5
WACC10.86%
ROIC/WACCN/A
Cap/Depr(3y)61.8%
Cap/Depr(5y)81.45%
Cap/Sales(3y)4.27%
Cap/Sales(5y)4.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-266.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next Y32.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.96%
Revenue growth 3Y5.76%
Revenue growth 5Y14.98%
Sales Q2Q%1.03%
Revenue Next Year15.82%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-930.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year169.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-96.37%
FCF growth 3Y-57.3%
FCF growth 5Y17.97%
OCF growth 1Y-75.79%
OCF growth 3Y-22.27%
OCF growth 5Y49.51%

INTELLINETICS INC / INLX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INTELLINETICS INC (INLX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to INLX.


Can you provide the valuation status for INTELLINETICS INC?

ChartMill assigns a valuation rating of 1 / 10 to INTELLINETICS INC (INLX). This can be considered as Overvalued.


How profitable is INTELLINETICS INC (INLX) stock?

INTELLINETICS INC (INLX) has a profitability rating of 2 / 10.


How financially healthy is INTELLINETICS INC?

The financial health rating of INTELLINETICS INC (INLX) is 4 / 10.